Claudia Rijcken

Claudia has an educational background as a pharmacist and obtained a PhD in Pharmacoepidemiology and a Master of Health Administration (eMBA).

After managing community pharmacy roles, she moved into clinical drug development in roles with inreasing responsibility at Organon and Novartis.

Next, she acted within Novartis in international leadership roles in patient access, key account management, and public affairs. Here, Claudia developed a growing passion to educate an facilitate the adequate use of digital health technology to further enhance the value of pharmaceutical care.

She invested in learning about business development and health technology at Erasmus University Rotterdam and MIT Sloan and moved into a European digital innovation role within Novartis.

In 2019, Claudia founded the company Pharmi BV which is located at the Philips High Tech Campus in Eindhoven, the Netherlands.

Pharmi develops interactive digital medication care modules that facilitate blended care support to patients. It offers pharmacists the possibility to provide care digitally where possible, freeing up more time to provide the ultimate important human care where needed. Pharmi’s platform MedsWise acts as an interactive digital coach for patients, warranting 24/7 patient access to reliable information, interaction and support at respective patient literacy levels and preferences.

Claudia is since 2019 also lecturer in digital pharmaceutical care for MSc Pharmacy students at the University of Utrecht, Netherlands. She regularly lectures on national and international events on digital pharmaceutical care and the transformation of care models.

Claudia is an active member of the FIP Technology Advisory Group.